Washington Trust Bank’s Merck MRK Stock Holding History

Washington Trust Bank’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.9M	Sell	132,592 -15,643	-11%	-$1.81M	1.18%	24
2025 Q4	$15.6M	Sell	148,235 -1,846	-1%	-$173K	1.09%	25
2025 Q3	$12.6M	Sell	150,081 -7,846	-5%	-$646K	0.92%	32
2025 Q2	$12.5M	Buy	157,927 +19,055	+14%	+$1.51M	1.05%	32
2025 Q1	$12.5M	Buy	138,872 +2,326	+2%	+$217K	1.25%	32
2024 Q4	$13.6M	Buy	136,546 +3,428	+3%	+$353K	1.3%	25
2024 Q3	$15.1M	Sell	133,118 -1,322	-1%	-$157K	1.45%	24
2024 Q2	$16.6M	Sell	134,440 -3,600	-3%	-$464K	1.65%	19
2024 Q1	$18.2M	Sell	138,040 -3,117	-2%	-$384K	1.74%	15
2023 Q4	$15.4M	Sell	141,157 -1,781	-1%	-$185K	1.36%	21
2023 Q3	$14.7M	Sell	142,938 -3,235	-2%	-$349K	1.54%	19
2023 Q2	$16.9M	Buy	146,173 +956	+0.7%	+$109K	1.72%	12
2023 Q1	$15.4M	Buy	145,217 +19,625	+16%	+$2.12M	1.65%	14
2022 Q4	$13.9M	Buy	125,592 +103,896	+479%	+$10.6M	1.58%	15
2022 Q3	$1.87M	Buy	21,696 +1,454	+7%	+$130K	0.24%	81
2022 Q2	$1.84M	Sell	20,242 -1,487	-7%	-$132K	0.24%	78
2022 Q1	$1.78M	Sell	21,729 -347	-2%	-$27.4K	0.21%	77
2021 Q4	$1.69M	Buy	22,076 +1,281	+6%	+$102K	0.16%	77
2021 Q3	$1.56M	Buy	20,795 +3,883	+23%	+$295K	0.18%	74
2021 Q2	$1.32M	Sell	16,912 -956	-5%	-$71.1K	0.16%	80
2021 Q1	$1.31M	Buy	17,868 +897	+5%	+$66.2K	0.16%	81
2020 Q4	$1.32M	Buy	16,971 +140	+0.8%	+$10.7K	0.17%	79
2020 Q3	$1.33M	Sell	16,831 -592	-3%	-$46.4K	0.2%	72
2020 Q2	$1.29M	Sell	17,423 -243	-1%	-$18.3K	0.2%	75
2020 Q1	$1.3M	Sell	17,666 -1,311	-7%	-$103K	0.25%	63
2019 Q4	$1.65M	Buy	18,977 +90	+0.5%	+$7.39K	0.23%	78
2019 Q3	$1.52M	Sell	18,887 -1,002	-5%	-$80.3K	0.25%	73
2019 Q2	$1.59M	Sell	19,889 -954	-5%	-$73K	0.26%	73
2019 Q1	$1.65M	Sell	20,843 -8,484	-29%	-$635K	0.26%	70
2018 Q4	$2.14M	Sell	29,327 -1,233	-4%	-$87K	0.28%	77
2018 Q3	$2.07M	Sell	30,560 -166	-0.5%	-$10.6K	0.31%	67
2018 Q2	$1.78M	Sell	30,726 -7,585	-20%	-$428K	0.25%	75
2018 Q1	$1.99M	Sell	38,311 -2,405	-6%	-$130K	0.29%	66
2017 Q4	$2.19M	Sell	40,716 -18	-0%	-$998	0.32%	64
2017 Q3	$2.49M	Buy	40,734 +1,550	+4%	+$94K	0.39%	56
2017 Q2	$2.4M	Sell	39,184 -382	-1%	-$23.3K	0.51%	46
2017 Q1	$2.4M	Buy	39,566 +3,734	+10%	+$227K	0.52%	45
2016 Q4	$2.01M	Sell	35,832 -231	-0.6%	-$13.5K	0.45%	54
2016 Q3	$2.15M	Buy	36,063 +3,027	+9%	+$177K	0.52%	49
2016 Q2	$1.82M	Sell	33,036 -320	-1%	-$17K	0.47%	50
2016 Q1	$1.68M	Buy	33,356 +349	+1%	+$17.1K	0.44%	47
2015 Q4	$1.66M	Buy	33,007 +2,545	+8%	+$128K	0.36%	56
2015 Q3	$1.44M	Buy	30,462 +1,588	+5%	+$84.4K	0.38%	59
2015 Q2	$1.57M	Sell	28,874 -19,865	-41%	-$1.11M	0.38%	55
2015 Q1	$2.67M	Buy	48,739 +11,173	+30%	+$633K	0.64%	26
2014 Q4	$2.04M	Sell	37,566 -1,253	-3%	-$69.8K	0.53%	45
2014 Q3	$2.2M	Sell	38,819 -3,838	-9%	-$216K	0.69%	26
2014 Q2	$2.35M	Buy	42,657 +1,855	+5%	+$101K	0.48%	60
2014 Q1	$2.21M	Buy	+40,802	New	+$2.11M	0.47%	59

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Washington Trust Bank's MRK Position: Q1 2026 in Review

Washington Trust Bank reduced its Merck (MRK) stake by 11% in Q1 2026, selling an estimated $1.81M and leaving 132,592 shares worth $15.9M. The position accounts for 1.18% of the portfolio, ranked #24.

Washington Trust Bank first reported a position in MRK in Q1 2014 and has held it in 49 quarters since. The position peaked at $18.2M in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Washington Trust Bank held 132,592 shares of Merck worth $15.9M as of Q1 2026.
Washington Trust Bank sold 15,643 Merck shares in Q1 2026, an estimated $1.81M.
Merck made up 1.18% of Washington Trust Bank's portfolio in Q1 2026, its #24 holding.
Washington Trust Bank first reported a position in Merck in Q1 2014 and has held it in 49 quarters since.
Washington Trust Bank's Merck position peaked at $18.2M in Q1 2024.
3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Washington Trust Bank's 13F filing for Q1 2026, filed 7 May 2026.